Search Results - David Paul Jenkins
- Showing 1 - 1 results of 1
-
1
Kv1.3 inhibition as a potential microglia-targeted therapy for Alzheimer’s disease: preclinical proof of concept by Izumi Maezawa, Hai M. Nguyen, Jacopo Di Lucente, David Paul Jenkins, Vikrant Singh, Silvia Hilt, Kyoungmi Kim, Srikant Rangaraju, Allan I. Levey, Heike Wulff, Lee‐Way Jin
Published 2017Artigo
Search Tools:
Related Subjects
Alzheimer's disease
Amyloid (mycology)
Biochemistry
Biology
Biotechnology
Cognitive decline
Dementia
Disease
Gene
Genetically modified mouse
Hippocampal formation
Immunology
In vivo
Inflammation
Internal medicine
Medicine
Microglia
Neuroinflammation
Neuroscience
Neurotoxicity
Pathology
Pharmacology
Toxicity
Transgene